Page 3 - பாரிஸ் வணிகரீதியானது நீதிமன்றம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021. at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021. Paris, 16 April 2021 - 6:00 p.m. CEST - Pixium Vision (Euronext Growth Paris - FR0011950641 - ALPIX), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independently, announces a cash position of €9.7 million at 31 March 2021 and reports on its key developments. Statement of cash flows summary In thousands of € 10,566.0 (818.4) (3,639.4) (10.8) 2,831.8 9,747.6 4,830.6 Net cash outflow from operating activities in the first three months of 2021 totalled €3.6 million, compared to €2.5 million one year earlier. The increased cash outflow was primarily due to the launch of the PRIMAvera clinical trial in Europe and the work begun in connection

Stanford universityUnited statesUnited kingdomFrance generalCity ofComunidad autonoma de catalunaGuillaume renondinGuillaume van renterghemSophie baumontSecond sight medical products incInstitute of ocular microsurgeryInnovative companyParis commercial courtPixium visionEuronext growth parisSecond sight medical products